about
Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics.A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas.CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue.Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion.Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.Home sweet home: the tumor microenvironment as a haven for regulatory T cells.Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment.Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodiesThe generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogenThe influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cellsDepletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in miceDepletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens
P50
Q33967185-A06CF51A-42A2-49D4-ACD3-302D477E5227Q35512402-AC0AAA4A-02AC-4D5D-A010-C07D37310120Q35545749-8DEB6AAD-6B38-4D56-8193-FAE0524A8536Q37194029-4F9AACEB-3307-4488-BC91-C865A1351EE5Q37455968-DA71D128-07D1-485B-8483-432835B12168Q37599511-E425CBEA-15FB-486F-AA5B-826E1A213719Q37706595-E9387807-7A09-4FB6-A4E2-D75512A2B881Q39418860-1A4ABFBD-A8A2-4BDA-9738-B8B474DDE1D7Q39832756-EBC5B3F2-ED7B-4910-A1B9-8A144E0D2AB0Q40470717-B06EB93B-131C-4350-BF10-A722DFD1059BQ41400520-C80D41F8-978B-4F53-8E38-744403E97E62Q41852491-7D1D16D8-896C-4F4F-9017-22690E952BD5Q43090164-1E00DC80-B292-4567-99EC-C9DFCBF1F510Q44037115-E2399201-1939-47F9-9037-D80C83F3D83BQ51061315-E75F53CC-26B6-4AE8-8844-C8FD086AAC0AQ56876471-F11D2054-3CE1-4045-A386-926A1D508472Q56902957-DD462A68-D5A7-414B-8D19-4A2D9DEAB605Q60311707-6EBC5270-91AE-469D-80F8-3A3B9C03B303Q61791934-B4053421-8581-43EC-97AB-283EF840CB46Q78852117-AEDAA632-5FA3-4177-968C-15DD90F29D36
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emma Jones
@ast
Emma Jones
@en
Emma Jones
@es
Emma Jones
@nl
Emma Jones
@sl
إيما جونز
@ar
type
label
Emma Jones
@ast
Emma Jones
@en
Emma Jones
@es
Emma Jones
@nl
Emma Jones
@sl
إيما جونز
@ar
prefLabel
Emma Jones
@ast
Emma Jones
@en
Emma Jones
@es
Emma Jones
@nl
Emma Jones
@sl
إيما جونز
@ar
P106
P21
P31
P496
0000-0002-0298-2859